Human ESRRA/ERR1/ERRa ORF/cDNA clone-Adeno-associate virus(AAV) particle (NM_004451.5)

Cat. No.: vGMAAV001454

Pre-made Human ESRRA/ERR1/ERRa Adeno-associated virus particle for ESRRA in-vivo study, mechanism of action (MOA) research and ESRRA-associated gene therapy development.

At GM Vector Core (GMVC), we stand at the forefront of custom AAV development and produce distinct grades of AAVs employing state-of-the-art methodologies. Uncover more about our expertise.

Target products collection

Go to ESRRA/ERR1 products collection>>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdf MSDS
pdf Datasheet

Product information

Catalog No. Product Name AAV serotype AAV Grade AAV quantity
vGMAAV001454 Human ESRRA Adeno-associate virus(AAV) particle AAV1, AAV2, AAV2 variant (Y444F), AAV2 variant (Y272F, Y444F, Y500F, Y730F), AAV2 variant (Y444F, Y730F, Y500F, Y272F, Y704F, Y252F), AAV2 variant(AAV2.7m8), AAV5, AAV6, AAV8, AAV8-1m, AAV8-2m, AAV8 variant (Y733F, Y447F, Y275), AAV9, AAV-Rh.10, AAV-DJ, AAV-DJ/8, AAV-Retro (Retrograde), AAV9-PHP.B, AAV9-PHP.eB, AAV9-PHP.S, AAV-BR1, AAV-2i8, AAV-SIG, AAV-VEC, AAV4, AAV6.2, AAV6.2FF Pilot Grade 1.0E+12VG/ml
5.0E+12VG/ml
1E+13VG/ml
5E+13VG/ml
1E+14VG/ml
Research Grade 1.0E+12VG/ml
5.0E+12VG/ml
1E+13VG/ml
5E+13VG/ml
1E+14VG/ml
GMP-like Grade inquiry
GMP Grade inquiry


Product Description

Catalog ID vGMAAV001454
Gene Name ESRRA
Accession Number NM_004451.5
Gene ID 2101
Species Human
Product Type Adeno-associate virus(AAV) particle (overexpression)
Insert Length 1272 bp
Gene Alias ERR1,ERRa,ERRalpha,ESRL1,NR3B1
Fluorescent Reporter Null
Mammalian Cell Selection Null
Fusion Tag 3xflag (C-Terminal)
Promoter CTNT
Resistance Amplicin

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    Target Antibody GM-Tg-g-T72841-Ab Anti-ESRRA monoclonal antibody
    Target Antigen GM-Tg-g-T72841-Ag ESRRA protein
    ORF Viral Vector pGMLV001369 Human ESRRA Lentivirus plasmid
    ORF Viral Vector pGMAD000107 Human ESRRA Adenovirus plasmid
    ORF Viral Vector pGMAAV001454 Human ESRRA Adeno-associate virus(AAV) plasmid
    ORF Viral Vector vGMLV001369 Human ESRRA Lentivirus particle
    ORF Viral Vector vGMAD000107 Human ESRRA Adenovirus particle
    ORF Viral Vector vGMAAV001454 Human ESRRA Adeno-associate virus(AAV) particle


    Target information

    Target ID GM-T72841
    Target Name ESRRA
    Gene ID 2101, 26379, 722085, 293701, 101099657, 403169, 507834, 100055615
    Gene Symbol and Synonyms ERR1,ERRa,ERRalpha,Errra,ESRL1,ESRRA,Estrra,NR3B1
    Uniprot Accession P11474
    Uniprot Entry Name ERR1_HUMAN
    Protein Sub-location Introcelluar Protein
    Category Therapeutics Target
    Disease Not Available
    Gene Ensembl ENSG00000173153
    Target Classification Nuclear Receptors

    The protein encoded by this gene is a nuclear receptor that is most closely related to the estrogen receptor. This protein acts as a site-specific transcription factor and interacts with members of the PGC-1 family of transcription cofactors to regulate the expression of most genes involved in cellular energy production as well as in the process of mitochondrial biogenesis. A processed pseudogene of ESRRA is located on chromosome 13q12.1. [provided by RefSeq, Jun 2019]



    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.